Soligenix, Inc. (SNGX)
NASDAQ: SNGX · IEX Real-Time Price · USD
0.405
+0.009 (2.15%)
At close: May 2, 2024, 4:00 PM
0.395
-0.010 (-2.35%)
Pre-market: May 3, 2024, 8:54 AM EDT
Soligenix Revenue
In the year 2023, Soligenix had annual revenue of $839.36K, a decrease of -11.55%. Revenue in the quarter ending December 31, 2023 was $244.81K, a -33.12% decrease year-over-year.
Revenue (ttm)
$839.36K
Revenue Growth
-11.55%
P/S Ratio
6.86
Revenue / Employee
$64,566
Employees
13
Market Cap
5.76M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 839.36K | -109.55K | -11.55% |
Dec 31, 2022 | 948.91K | 124.64K | 15.12% |
Dec 31, 2021 | 824.27K | -1.54M | -65.07% |
Dec 31, 2020 | 2.36M | -2.27M | -49.04% |
Dec 31, 2019 | 4.63M | -611.53K | -11.67% |
Dec 31, 2018 | 5.24M | -191.02K | -3.52% |
Dec 31, 2017 | 5.43M | -5.02M | -48.01% |
Dec 31, 2016 | 10.45M | 1.68M | 19.16% |
Dec 31, 2015 | 8.77M | 1.73M | 24.50% |
Dec 31, 2014 | 7.04M | 3.82M | 118.45% |
Dec 31, 2013 | 3.22M | 79.53K | 2.53% |
Dec 31, 2012 | 3.14M | -4.52M | -58.96% |
Dec 31, 2011 | 7.66M | 5.72M | 293.44% |
Dec 31, 2010 | 1.95M | -868.41K | -30.84% |
Dec 31, 2009 | 2.82M | 505.77K | 21.89% |
Dec 31, 2008 | 2.31M | 1.05M | 83.64% |
Dec 31, 2007 | 1.26M | -1.06M | -45.61% |
Dec 31, 2006 | 2.31M | -762.72K | -24.80% |
Dec 31, 2005 | 3.08M | 2.08M | 208.35% |
Dec 31, 2004 | 997.48K | 913.67K | 1,090.07% |
Dec 31, 2003 | 83.82K | - | - |
Dec 31, 2002 | 0 | - | - |
Dec 31, 2001 | 0 | - | - |
Dec 31, 2000 | 0 | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 0 | - | - |
Dec 31, 1996 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Triangle | 33.20M |
ThermoGenesis Holdings | 9.45M |
Sintx Technologies | 2.63M |
Xenetic Biosciences | 2.54M |
Sonnet BioTherapeutics Holdings | 129.18K |
SNGX News
- 8 days ago - Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa - PRNewsWire
- 15 days ago - Soligenix Announces Pricing of $4.75 Million Public Offering - PRNewsWire
- 18 days ago - FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection - PRNewsWire
- 22 days ago - FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection - PRNewsWire
- 4 weeks ago - Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency - PRNewsWire
- 7 weeks ago - Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results - PRNewsWire
- 3 months ago - Soligenix Announces Formation of Behçet's Disease Medical Advisory Board - PRNewsWire
- 3 months ago - Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire